Selling by month
Oct 2025 to Oct 2026. Each sale is counted once: under a disclosed plan, else to cover taxes, else no plan disclosed.
Disclosed planOne dollar scale for every month; the tallest bar is labeled
Pattern
What the filings show, past 12 months. Nothing here rates or predicts.
- Sold in 3 of the 13 calendar months from Oct 2025 to Oct 2026: May 2026, Jul 2026 and Aug 2026.
- Largest single sale: $2.0M (26,756 shares) of Dexcom on Jul 20, 2026. Filing
- Last sale before this period: Mar 12, 2025.
Roles from filings
Every company we track where this person has filed, newest filing first.
| Company | Title | First filing | Latest filing |
|---|---|---|---|
| Dexcom (DXCM) | Executive Chair, Director | Nov 8, 2007 | Aug 24, 2026 |
Recent filings
The last 5 days with transactions, newest first, one line per trade date. Each number links to an SEC filing.
- Aug 20, 2026, Dexcom: sold 26,756 shares for $2.4M, under a disclosed plan. 1 filing: 1
- Jul 20, 2026, Dexcom: sold 26,756 shares for $2.0M, under a disclosed plan. 1 filing: 1
- Jul 6, 2026, Dexcom: sold 26,756 shares for $1.9M, under a disclosed plan. 1 filing: 1
- May 21, 2026, Dexcom: sold 26,759 shares for $1.9M, under a disclosed plan. 1 filing: 1
- Mar 8, 2026, Dexcom: 32,749 shares granted; 32,498 shares withheld by the company for taxes. 1 filing: 1
This page shows only what this person reported on SEC ownership filings. See the methodology. Spotted something wrong? Report an error.